I don't think you have provided a persuasive argument (or any argument actually) for the contention that Microsoft's performance has a relation to the performance of a pharmaceutical company.
Drug development is hit-or-miss like software development. But that's about it.
Unlike drug development, software development often involves creating and maintaining a platform that will give you profits for years to come - or failing miserably and spectacularly. Microsoft's recent performance has been beyond abysmal and they've only only survived on the profits from their previous successes at building a platform - many people are still forced to use Windows. But everyone is looking around and the prospects look, uh, dim.
Sure, Microsoft doesn't live quarter to quarter. Which is why it's death is not yet finished but that's about it.
They made more money in the last 3 months than any tech company on earth save for Apple and you're writing as though they are an almost dead, twitching patient in a hospice.
For a group of smart people who at least consider themselves open-minded and objective, an astonishing amount of stupidly closed-minded things are said about Microsoft.
> For a group of smart people who at least consider themselves open-minded and objective, an astonishing amount of stupidly closed-minded things are said about Microsoft.
completely agree. My question to everybody who's out there with their knives and fork is this,
so microsoft's surface tablets lost a lot of money and did not sell , you think companies like microsoft and google should quit trying to compete with apple for gaining tablet market share ?
I believe the next iteration would fare much better and win 8.1 or maybe even win 9 could be when we begin to see microsoft gaining market share in mobile device sales.
I'm not a MS fanboy by any stretch of the imagination but, and you have to realize this, MS already has that platform. They're so far ahead with said platform that all of this is just play money to them and they have ample time to invest heavily into R&D.
No other platform is even remotely ready for corporate environment. Not by a long shot. The billions invested in Windows software by every company on the planet means incredible vendor lock and the momentum required to move past that is so immense that is just not possible.
Any possibility of their "death" is ridiculous. This is just a slight bump in the road for them, they'll shift strategy and lather, rinse, repeat.
I don't think you have provided a persuasive argument (or any argument actually) for the contention that Microsoft's performance has a relation to the performance of a pharmaceutical company.
Drug development is hit-or-miss like software development. But that's about it.
Unlike drug development, software development often involves creating and maintaining a platform that will give you profits for years to come - or failing miserably and spectacularly. Microsoft's recent performance has been beyond abysmal and they've only only survived on the profits from their previous successes at building a platform - many people are still forced to use Windows. But everyone is looking around and the prospects look, uh, dim.
Sure, Microsoft doesn't live quarter to quarter. Which is why it's death is not yet finished but that's about it.